ADMA BIOLOGICS, INC. (ADMA)

9.34USD -1.48% (-0.14)

Over 1M: +10.4%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

8.5 9 9.5 10
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Operating Cash Flow: 13.3M Q3 '25 — Net Income: 36.4M Q4 '25 — Operating Cash Flow: 35.6M Q4 '25 — Net Income: 49.4M Q1 '26 — Operating Cash Flow: 58.2M Q1 '26 — Net Income: 45.3M Q2 '26 — Operating Cash Flow: 29.5M Q2 '26 — Net Income: 37.8M 0 15M 30M 45M 60M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 62 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

7.8
Oper. margin 43.8%
ROIC 37.5%
OE margin 18.3%
FCF margin 22.7%
ROA 24.7%
ROCE 36.9%
ROE 41.4%
Gross margin 64.7%
OCF margin 26.7%
Accruals 4.7%
OCF / EBIT 0.61×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

8.8
EV/EBIT 9.7×
EV/OE 23.3×
P/E 12.5×
EV/GP 6.6×
FCF yield 5.5%
P/C 15.5×
EV/Sales 4.3×
P/B 5.2×
Div. yield —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.2
RPO / sales 0.00028×
Segment HHI 0.97 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.3
ND/EBITDA -0.03
Debt payback 0.55 yr
Net debt / Eq 0.16×
Payout 0.0%
Quick ratio 3.8×
Cash / Debt 0.68×
Debt / Eq 0.49×
F-score 5.0 pts
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.1
Sales CAGR 4Y +58.4%
Sales/sh Y/Y +7.3%
EBIT Y/Y +44.2%
Shares change +0.64%
EPS Y/Y -19.6%
Sales Q/Q +2.0%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.